Published Date: 08 Mar 2023
Italy's biggest conglomerate, Intesa Sanpaolo, has paid 360 million euros ($382 million) in cash to acquire a 26.2% stake in health insurer Intesa Sanpaolo RBM Salute, which it does not own. that it will be used.
Read Full NewsThe U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet to treat infestations caused by the New World screwworm...
Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.
A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.
A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.
Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.
Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...
Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World Health Organization said, as the outbreak of the dangerous...
1.
FDA Approves Novel Targeted Therapy for Rare Blood Cancer
2.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
3.
The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.
4.
10-year study shows tomosynthesis improves breast cancer detection
5.
Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.
1.
Uncovering the Mystery of the Sessile Serrated Adenoma
2.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
3.
Practical Developments in Hematology in the Digital Era
4.
Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options
5.
Patient-Centric Approaches in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation